Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/GALENA-BIOPHARMA-INC-11900113/news/Galena-Biopharma-Enrolls-700th-Patient-in-NeuVax-TM-nelipepimut-S-Phase-3-PRESENT-Clinical-Trial-19835083/?utm_source=whatsapp&utm_medium=social&utm_campaign=share